The issue of addressing potential nitrosamine impurities in medicines has been the focus at events taking place around the globe in recent months and will continue to do so throughout 2023.
Substandard medicines are a huge public health threat. Proactively evaluating drug products using a relative risk assessment is important to reduce the prevalence of substandard antibiotics.
Revised on: January 17, 2023
Persistent and long-lasting shortages of childhood cancer treatments undermine the advancements in science that have helped to increase childhood cancer survival rates to 85 percent.
The challenges posed by COVID-19 transcend international borders and require global solutions. This includes addressing the potential for substandard and falsified (SSF) COVID-19 vaccines, particularly in low- and middle-income countries. At the U.S.
Show 11 More